Role of nanoparticle valency in the nondestructive magnetic-relaxation-mediated detection and magnetic isolation of cells in complex media.
Nanoparticle-based diagnostics typically involve the conjugation of targeting ligands to the nanoparticle to create a sensitive and specific nanosensor that can bind and detect the presence of a target, such as a bacterium, cancer cell, protein, or DNA sequence. Studies that address the effect of multivalency on the binding and detection pattern of these nanosensors, particularly on magnetic relaxation nanosensors that sense the presence of a target in a dose-dependent manner by changes in the water relaxation times (DeltaT2), are scarce. Herein, we study the effect of multivalency on the detection profile of cancer cells and bacteria in complex media, such as blood and milk. In these studies, we conjugated folic acid at two different densities (low-folate and high-folate) on polyacrylic-acid-coated iron oxide nanoparticles and studied the interaction of these magnetic nanosensors with cancer cells expressing the folate receptor. Results showed that the multivalent high-folate magnetic relaxation nanosensor performed better than its low folate counterpart, achieving single cancer cell detection in blood samples within 15 min. Similar results were also observed when a high molecular weight anti-folate antibody (MW 150 kDa) was used instead of the low molecular weight folic acid ligand (MW 441.4 kDa), although better results in terms of sensitivity, dynamic range, and speed of detection were obtained when the folate ligand was used. Studies using bacteria in milk suspensions corroborated the results observed with cancer cells. Taken together, these studies demonstrate that nanoparticle multivalency plays a key role in the interaction of the nanoparticle with the cellular target and modulate the behavior and sensitivity of the assay. Furthermore, as detection with magnetic relaxation nanosensors is a nondestructive technique, magnetic isolation and further characterization of the cancer cells is possible.
Kaittanis
Charalambos
C
Nanoscience Technology Center, University of Central Florida, 12424 Research Parkway, Suite 400, Orlando, Florida 32826, USA.
Santra
Santimukul
S
Perez
J Manuel
JM
D000345:Affinity Labels / Q000737:chemistry / Q000378:metabolism; D000818:Animals; D001419:Bacteria / Q000166:cytology / Q000302:isolation & purification / Q000378:metabolism; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D002469:Cell Separation / Q000379:methods*; D003124:Colorimetry; D005290:Ferric Compounds / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D008024:Ligands; D008280:Magnetics; D053758:Nanoparticles / Q000737:chemistry*; D009195:Peroxidase / Q000378:metabolism; D051381:Rats
D000345:Affinity Labels; D005290:Ferric Compounds; D008024:Ligands; C000499:ferric oxide; D009195:Peroxidase
Clin Cancer Res. 2008 Aug 15;14(16):5013-21
18698019
Nature. 2007 Dec 20;450(7173):1235-9
18097410
Cell. 2009 May 1;137(3):433-44
19410541
Cancer Res. 2004 Jan 15;64(2):639-43
14744779
Magn Reson Med. 1993 May;29(5):599-604
8505895
Neoplasia. 2008 Oct;10(10):1066-72
18813356
Clin Cancer Res. 2004 May 1;10(9):3020-8
15131038
J Am Chem Soc. 2008 Dec 24;130(51):17214-5
19053187
Nano Lett. 2007 Feb;7(2):380-3
17298004
Adv Exp Med Biol. 2007;608:87-100
17993234
Clin Cancer Res. 2000 Sep;6(9):3552-9
10999743
Curr Opin Cell Biol. 2006 Oct;18(5):463-71
16919434
Nat Nanotechnol. 2007 Sep;2(9):535-6
18654361
Acc Chem Res. 2005 Sep;38(9):723-32
16171315
Curr Opin Infect Dis. 2008 Jun;21(3):279-86
18448973
Cancer Metastasis Rev. 2007 Dec;26(3-4):567-78
17786537
Nature. 2008 Dec 4;456(7222):593-8
19052619
Org Biomol Chem. 2004 Dec 7;2(23):3409-24
15565230
Curr Opin Cell Biol. 2008 Oct;20(5):551-6
18583124
Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17073-4
17090687
Chem Mater. 2009 Apr 28;21(8):1761-1767
20204168
Curr Opin Chem Biol. 2004 Dec;8(6):617-25
15556405
Nat Nanotechnol. 2007 Sep;2(9):577-83
18654371
Bioconjug Chem. 2003 Nov-Dec;14(6):1115-21
14624624
Nat Biotechnol. 2002 Aug;20(8):816-20
12134166
Adv Cancer Res. 2001;80:147-87
11034543
J Am Chem Soc. 2003 Aug 27;125(34):10192-3
12926940
Anal Biochem. 2005 Mar 15;338(2):284-93
15745749
J Am Chem Soc. 2008 Jun 4;130(22):6896-7
18473457
PLoS One. 2008 Sep 23;3(9):e3253
18810269
Nat Med. 2008 Aug;14(8):869-74
18607350
Angew Chem Int Ed Engl. 2006 Apr 3;45(15):2348-68
16557636
Small. 2009 Aug 17;5(16):1862-8
19384879